Market Cap 96.09M
Revenue (ttm) 66.58M
Net Income (ttm) -19.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.96%
Debt to Equity Ratio 1.31
Volume 878,100
Avg Vol 389,992
Day's Range N/A - N/A
Shares Out 24.14M
Stochastic %K 70%
Beta 1.81
Analysts Strong Sell
Price Target $8.67

Company Profile

Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of complex rheumatic, and autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company's lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms in...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 760 560 1501
Address:
1261 Liberty Way, Suite C, Vista, United States
totumfaktum88
totumfaktum88 May. 12 at 4:14 PM
$XGN Trump…
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES May. 12 at 1:43 PM
$XGN Adds!! $4.00 Again no reason this dipped.... Big money coming imo watch the bounce 🚨🚨
1 · Reply
ToBTrades
ToBTrades May. 12 at 1:35 PM
$XGN perfect..now go back where you came from and more
0 · Reply
Flex879
Flex879 May. 12 at 1:32 PM
$XGN 😬😬😬😬😬😬
0 · Reply
STACKD0E
STACKD0E May. 12 at 1:18 PM
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES May. 12 at 12:50 PM
$XGN Adds! Why not go over $4.00🚨🚨
0 · Reply
AveraveJoeTrader
AveraveJoeTrader May. 12 at 12:32 PM
$HIVE $LXRX $XGN Why are they getting attention? 👇🏻🎉 https://x.com/autumnsdad1/status/2054155500590080393?s=61
0 · Reply
topstockalerts
topstockalerts May. 12 at 12:56 AM
$XGN every red candle gets erased
0 · Reply
topstockalerts
topstockalerts May. 11 at 9:32 PM
Top Gainers PT2 $PRSO $GSIT $XGN $BZH $YMAT
0 · Reply
GSP
GSP May. 11 at 8:41 PM
Your Day Trading Watch List for May 12th in 2 Minutes (con't): $SMR $XGN $SIDU $SATL $DFDV
0 · Reply
Latest News on XGN
Exagen price target lowered to $8 from $9 at BTIG

2026-05-12T11:50:22.000Z - 23 hours ago

Exagen price target lowered to $8 from $9 at BTIG


Exagen reports Q1 EPS (17c), consensus (25c)

2026-05-11T16:09:37.000Z - 1 day ago

Exagen reports Q1 EPS (17c), consensus (25c)


Exagen Earnings Call Transcript: Q1 2026

May 11, 2026, 8:30 AM EDT - 1 day ago

Exagen Earnings Call Transcript: Q1 2026


Exagen Inc. Reports First Quarter 2026 Results

May 11, 2026, 8:00 AM EDT - 1 day ago

Exagen Inc. Reports First Quarter 2026 Results


Exagen price target lowered to $8 from $10 at Canaccord

2026-04-20T13:56:34.000Z - 22 days ago

Exagen price target lowered to $8 from $10 at Canaccord


Exagen price target lowered to $10 from $12 at Craig-Hallum

2026-03-11T13:21:32.000Z - 2 months ago

Exagen price target lowered to $10 from $12 at Craig-Hallum


Exagen price target lowered to $10 from $15 at Canaccord

2026-03-11T11:10:32.000Z - 2 months ago

Exagen price target lowered to $10 from $15 at Canaccord


Exagen price target lowered to $10 from $15 at KeyBanc

2026-03-11T10:36:24.000Z - 2 months ago

Exagen price target lowered to $10 from $15 at KeyBanc


Exagen price target lowered to $9 from $10 at BTIG

2026-03-10T19:45:16.000Z - 2 months ago

Exagen price target lowered to $9 from $10 at BTIG


Exagen Earnings Call Transcript: Q4 2025

Mar 10, 2026, 8:30 AM EDT - 2 months ago

Exagen Earnings Call Transcript: Q4 2025


Exagen reports Q4 EPS (20c), consensus (19c)

2026-03-10T12:12:45.000Z - 2 months ago

Exagen reports Q4 EPS (20c), consensus (19c)


Exagen sees FY26 revenue $70M-$73M, consensus $73.84M

2026-03-10T12:12:08.000Z - 2 months ago

Exagen sees FY26 revenue $70M-$73M, consensus $73.84M


Exagen Inc. to Participate in Upcoming Investor Conferences

Mar 3, 2026, 9:00 AM EST - 2 months ago

Exagen Inc. to Participate in Upcoming Investor Conferences


Exagen price target lowered to $10 from $13 at TD Cowen

2026-02-24T13:44:49.000Z - 2 months ago

Exagen price target lowered to $10 from $13 at TD Cowen


Exagen price target lowered to $10 from $15 at BTIG

2026-02-17T12:21:41.000Z - 3 months ago

Exagen price target lowered to $10 from $15 at BTIG


Exagen price target lowered to $8 from $18 at B. Riley

2026-01-30T13:37:01.000Z - 3 months ago

Exagen price target lowered to $8 from $18 at B. Riley


Exagen Inc. Announces Select Preliminary 2025 Financial Results

Jan 11, 2026, 3:00 PM EST - 4 months ago

Exagen Inc. Announces Select Preliminary 2025 Financial Results


Exagen price target lowered to $13 from $18 at TD Cowen

2026-01-07T14:15:25.000Z - 4 months ago

Exagen price target lowered to $13 from $18 at TD Cowen


Exagen management to meet virtually with B. Riley

2025-11-14T15:50:22.000Z - 6 months ago

Exagen management to meet virtually with B. Riley


Exagen price target raised to $15 from $13 at BTIG

2025-11-10T12:25:18.000Z - 6 months ago

Exagen price target raised to $15 from $13 at BTIG


Exagen price target raised to $18 from $15 at B. Riley

2025-11-05T13:41:20.000Z - 6 months ago

Exagen price target raised to $18 from $15 at B. Riley


Exagen Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:30 AM EST - 6 months ago

Exagen Earnings Call Transcript: Q3 2025


Exagen reports Q3 EPS (31c), consensus (16c)

2025-11-04T13:10:34.000Z - 6 months ago

Exagen reports Q3 EPS (31c), consensus (16c)


Exagen Inc. Reports Strong Q3 2025 Results

Nov 4, 2025, 8:00 AM EST - 6 months ago

Exagen Inc. Reports Strong Q3 2025 Results


Exagen Earnings Call Transcript: Q2 2025

Jul 29, 2025, 8:30 AM EDT - 10 months ago

Exagen Earnings Call Transcript: Q2 2025


Exagen Inc. Reports Strong Q2 2025 Results

Jul 29, 2025, 8:00 AM EDT - 10 months ago

Exagen Inc. Reports Strong Q2 2025 Results


Exagen Inc. Appoints Chas McKhann to Board of Directors

Jul 17, 2025, 4:05 PM EDT - 10 months ago

Exagen Inc. Appoints Chas McKhann to Board of Directors


Exagen Inc. Prices Public Offering of Common Stock

May 8, 2025, 8:30 AM EDT - 1 year ago

Exagen Inc. Prices Public Offering of Common Stock


Exagen Earnings Call Transcript: Q1 2025

May 5, 2025, 8:30 AM EDT - 1 year ago

Exagen Earnings Call Transcript: Q1 2025


Exagen Earnings Call Transcript: Q4 2024

Mar 11, 2025, 8:30 AM EDT - 1 year ago

Exagen Earnings Call Transcript: Q4 2024


Exagen Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Exagen Earnings Call Transcript: Q3 2024


Exagen Earnings Call Transcript: Q2 2024

Aug 5, 2024, 8:30 AM EDT - 1 year ago

Exagen Earnings Call Transcript: Q2 2024


Exagen Earnings Call Transcript: Q1 2024

May 13, 2024, 8:30 AM EDT - 2 years ago

Exagen Earnings Call Transcript: Q1 2024


Exagen to Announce First Quarter 2024 Results on May 13, 2024

Apr 30, 2024, 4:05 PM EDT - 2 years ago

Exagen to Announce First Quarter 2024 Results on May 13, 2024


Exagen Inc. Announces Changes to the Board of Directors

Apr 26, 2024, 8:30 AM EDT - 2 years ago

Exagen Inc. Announces Changes to the Board of Directors


Exagen Earnings Call Transcript: Q4 2023

Mar 18, 2024, 8:30 AM EDT - 2 years ago

Exagen Earnings Call Transcript: Q4 2023


Exagen Earnings Call Transcript: Q3 2023

Nov 13, 2023, 4:30 PM EST - 2 years ago

Exagen Earnings Call Transcript: Q3 2023


Exagen Inc. Reports Strong Third Quarter 2023 Results

Nov 13, 2023, 4:05 PM EST - 2 years ago

Exagen Inc. Reports Strong Third Quarter 2023 Results


Exagen Earnings Call Transcript: Q2 2023

Aug 7, 2023, 8:30 AM EDT - 3 years ago

Exagen Earnings Call Transcript: Q2 2023


Exagen Inc. Reports Strong Second Quarter 2023 Results

Aug 7, 2023, 8:00 AM EDT - 3 years ago

Exagen Inc. Reports Strong Second Quarter 2023 Results


Exagen Inc. Appoints Paul Kim to Board of Directors

Jul 24, 2023, 4:05 PM EDT - 3 years ago

Exagen Inc. Appoints Paul Kim to Board of Directors


Exagen Earnings Call Transcript: Q1 2023

May 15, 2023, 4:30 PM EDT - 3 years ago

Exagen Earnings Call Transcript: Q1 2023


Exagen Inc. Reports First Quarter 2023 Results

May 15, 2023, 4:05 PM EDT - 3 years ago

Exagen Inc. Reports First Quarter 2023 Results


Exagen Earnings Call Transcript: Q4 2022

Mar 20, 2023, 4:30 PM EDT - 3 years ago

Exagen Earnings Call Transcript: Q4 2022


Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results

Mar 20, 2023, 4:05 PM EDT - 3 years ago

Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results


totumfaktum88
totumfaktum88 May. 12 at 4:14 PM
$XGN Trump…
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES May. 12 at 1:43 PM
$XGN Adds!! $4.00 Again no reason this dipped.... Big money coming imo watch the bounce 🚨🚨
1 · Reply
ToBTrades
ToBTrades May. 12 at 1:35 PM
$XGN perfect..now go back where you came from and more
0 · Reply
Flex879
Flex879 May. 12 at 1:32 PM
$XGN 😬😬😬😬😬😬
0 · Reply
STACKD0E
STACKD0E May. 12 at 1:18 PM
0 · Reply
PLATINUM_TRADES
PLATINUM_TRADES May. 12 at 12:50 PM
$XGN Adds! Why not go over $4.00🚨🚨
0 · Reply
AveraveJoeTrader
AveraveJoeTrader May. 12 at 12:32 PM
$HIVE $LXRX $XGN Why are they getting attention? 👇🏻🎉 https://x.com/autumnsdad1/status/2054155500590080393?s=61
0 · Reply
topstockalerts
topstockalerts May. 12 at 12:56 AM
$XGN every red candle gets erased
0 · Reply
topstockalerts
topstockalerts May. 11 at 9:32 PM
Top Gainers PT2 $PRSO $GSIT $XGN $BZH $YMAT
0 · Reply
GSP
GSP May. 11 at 8:41 PM
Your Day Trading Watch List for May 12th in 2 Minutes (con't): $SMR $XGN $SIDU $SATL $DFDV
0 · Reply
topstockalerts
topstockalerts May. 11 at 8:06 PM
$XGN yeah… this one just earned a spot on my watchlist today
0 · Reply
Djreda
Djreda May. 11 at 6:49 PM
$XGN one to watch for continuation
0 · Reply
FonsieTrader
FonsieTrader May. 11 at 6:43 PM
$XGN strong all day
0 · Reply
MarketBeat
MarketBeat May. 11 at 5:11 PM
https://marketbeat.com/a/8648618/ $XGN Exagen Q1 Earnings Call Highlights
0 · Reply
deepthinker
deepthinker May. 11 at 4:46 PM
$TRIB $XGN figured out how turn a NY State lab into a compressive autoimmune business. Trinity didn’t. Given the intro of new tests, I wonder if there’s not something possible there. Perceptive controls both companies, interestingly enough.
0 · Reply
EarningsInsider
EarningsInsider May. 11 at 3:47 PM
https://www.marketbeat.com/earnings/reports/2026-5-11-exagen-inc-stock/ $XGN Exagen Earnings Transcript
0 · Reply
wildwesttrader
wildwesttrader May. 11 at 2:53 PM
$LXRX $MNTS $ODYS $VIVO $XGN Hate these types of posts. We aren’t done yet imo. Lots of room to climb next 6 months.
0 · Reply
MVPMPMVP
MVPMPMVP May. 11 at 2:50 PM
$VIVO its take off time- it will sudden, it will be quick, and you will miss it!!!!!! Take your profits from $$ODYS $XGN $LXRX $MNTS and join us here at $VIVO
0 · Reply
M105
M105 May. 11 at 2:48 PM
$XGN insider buys… very persuasive
0 · Reply
KUMO2026
KUMO2026 May. 11 at 2:48 PM
$XGN bottom swing trade
0 · Reply
M105
M105 May. 11 at 2:38 PM
$XGN This is very persuasive
0 · Reply
WallStreetVice
WallStreetVice May. 11 at 2:34 PM
0 · Reply